%20(2).jpg)
Following IMCAS 2026, Kokuma officially welcomes Dr. Michael Gold as Scientific Advisor. In a post-IMCAS expert Q&A, Dr. Gold shares why consistency across skin types is critical in pigmentation care and how biotech-driven actives are reshaping dermatology and skincare innovation.
Read more
Premium Beauty News highlights Kokuma’s latest clinical results on Tonasulike-D®, its AI-discovered depigmenting active unveiled at IFSCC 2025 and Cosmetic 360. Proven effective at just 0.01%, Tonasulike-D delivers visible brightening and dark spot reduction across all skin tones, setting a new benchmark for safe and inclusive skincare innovation.
Read more